Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept.
Aurelio Seidita, Alessandra Giuliano, Maurizio Soresi...
https://pubmed.ncbi.nlm.nih.gov/38609737/Actively Recruiting
Led by University of Palermo · Updated on 2025-06-22
100
Participants Needed
2
Research Sites
569 weeks
Total Duration
Researchers are studying adults aged 18 to 65 with symptoms similar to irritable bowel syndrome IBS who may have not-celiac wheat sensitivity NCWS. This condition causes symptoms after eating wheat but is not celiac disease or wheat allergy. The study aims to identify biological markers and better understand NCWS by comparing patients who improve on a gluten-free diet but worsen when wheat is reintroduced. Participants will be randomly assigned to receive either wheat flour or a placebo xylose three times daily for 15 days in a double-blind setup. Before this challenge, patients will follow a gluten-free diet and may also follow a more restricted elimination diet if multiple food sensitivities are suspected. The study will collect blood, stool, and tissue samples via endoscopic biopsies to analyze immune and biochemical responses. During the study, researchers will monitor gastrointestinal symptoms using the Gastrointestinal Symptom Rating Scale and evaluate changes in biological markers before and after the dietary challenge. The trial includes careful symptom tracking, laboratory tests, and biopsies to help diagnose NCWS and understand its causes. The study is expected to continue until December 2026.
CONDITIONS
Bio-markers of Not-celiac Wheat Sensitivity
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Palermo
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants undergo tests to exclude celiac disease and wheat allergy before enrollment.
Duration - Variable pre-treatment period before intervention
Participants follow an oligoantigenic diet followed by a gluten-free diet (GFD) to identify symptom changes and confirm suspected Not-celiac Wheat Sensitivity (NCWS).
Visits occur during diet changes for symptom and biomarker assessments.
Duration - 15 days
Participants receive either wheat flour or placebo (Xylose) three times per day for 15 days to evaluate symptom response and identify biomarkers of NCWS.
Participants have regular visits during the 15-day intervention period for monitoring symptoms and collecting biomarker data.
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Aurelio Seidita, Alessandra Giuliano, Maurizio Soresi...
https://pubmed.ncbi.nlm.nih.gov/38609737/Antonio Carroccio, Giulio Giannone, Pasquale Mansueto...
https://pubmed.ncbi.nlm.nih.gov/30138736/University of Palermo
Lead Sponsor